Agilent Technologies Operating Expenses 2011-2026 | A

Annual Operating Expenses Agilent Technologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	1.99 B	1.86 B	1.76 B	1.57 B	1.58 B	1.52 B	2.76 B	2.58 B	2.48 B	2.46 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.76 B	1.52 B	2.06 B

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	58 M	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	13.8 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	41.3 M	$ 1.16	-1.69 %	$ 6.32 M	USA
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	411 M	$ 16.69	-6.86 %	$ 889 M	USA
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Burning Rock Biotech Limited BNR	726 M	$ 16.25	0.06 %	$ 175 M	China
Exact Sciences Corporation EXAS	2.47 B	-	-	$ 19.8 B	USA
Co-Diagnostics CODX	50.6 M	$ 4.4	101.83 %	$ 5.85 M	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	59.5 M	$ 23.43	-6.99 %	$ 651 M	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	607 M	$ 175.55	0.27 %	$ 8.7 B	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Danaher Corporation DHR	6.71 B	$ 192.99	-1.63 %	$ 138 B	USA
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	20 M	$ 2.3	16.02 %	$ 10.2 M	USA
Illumina ILMN	3.69 B	$ 123.67	-3.38 %	$ 19.7 B	USA
Fulgent Genetics FLGT	181 M	$ 15.02	-5.12 %	$ 454 M	USA
Koninklijke Philips N.V. PHG	7.12 B	$ 28.13	0.29 %	$ 20 B	Niderland
Guardant Health GH	226 M	$ 87.17	-6.11 %	$ 10.9 B	USA
QIAGEN N.V. QGEN	821 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	9.98 M	$ 2.74	0.37 %	$ 88.9 K	USA
Biomerica BMRA	5.64 M	$ 2.2	2.33 %	$ 5.05 M	USA
ICON Public Limited Company ICLR	408 M	$ 106.7	0.15 %	$ 8.8 B	Irlanda
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
Laboratory Corporation of America Holdings LH	1.87 B	$ 273.26	-0.53 %	$ 22.7 B	USA
Celcuity CELC	172 M	$ 124.64	6.58 %	$ 5.83 B	USA
Medpace Holdings MEDP	118 M	$ 501.5	-3.68 %	$ 14.5 B	USA
Lantheus Holdings LNTH	123 M	$ 81.43	1.75 %	$ 5.5 B	USA
Motus GI Holdings MOTS	18.6 M	-	-34.28 %	$ 263 K	Israel
Myriad Genetics MYGN	964 M	$ 4.44	-6.92 %	$ 411 M	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 197.82	-0.5 %	$ 22 B	USA
NeoGenomics NEO	430 M	$ 7.94	-3.38 %	$ 1.02 B	USA
Neogen Corporation NEOG	1.48 B	$ 10.04	-2.95 %	$ 2.18 B	USA
ENDRA Life Sciences NDRA	5.76 M	$ 5.31	2.71 %	$ 4.18 M	USA
National Research Corporation NRC	38.5 M	$ 17.05	-1.22 %	$ 382 M	USA
Natera NTRA	258 M	$ 203.0	-3.71 %	$ 20 B	USA
Invitae Corporation NVTA	343 M	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	23.3 M	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	21.9 M	-	-16.95 %	$ 1.54 M	USA